CIAFARDINI, CLORINDA
CIAFARDINI, CLORINDA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Risankizumab, but not ustekinumab or vedolizumab, downregulates IL-23-induced mucosal pathogenic Th17 cells in patients with Crohn’s disease
2024 D. Noviello, I. Dusetti, V. Pivorunas, A.E. Lovati, C. Ciafardini, C. Amoroso, F. Conforti, N. Piazza O Sed, M. Vecchi, F. Facciotti, M. Paroni, F. Caprioli
Serum zonulin and colorectal cancer risk
2024 M. Marino, S. Mignozzi, K.B. Michels, M. Cintolo, R. Penagini, G. Gargari, C. Ciafardini, M. Ferraroni, L. Patel, C. Del Bo', P. Leone, A. Airoldi, M. Vecchi, R. Bonzi, B. Oreggia, P. Carnevali, M. Vangeli, M. Mutignani, S. Guglielmetti, P. Riso, C. La Vecchia, M. Rossi
Garlic consumption in relation to colorectal cancer risk and to alterations of blood bacterial DNA
2023 M.C. Speciani, G. Gargari, R. Penagini, M. Mutignani, M. Ferraroni, A. Natale, M. Katsoulis, M. Cintolo, P. Leone, A. Airoldi, M. Vecchi, R. Bonzi, C. Ciafardini, B. Oreggia, P. Carnevali, S. Guglielmetti, P. Riso, C. La Vecchia, M. Rossi
Flavonoid Intake in Relation to Colorectal Cancer Risk and Blood Bacterial DNA
2022 M.C. Speciani, M. Cintolo, M. Marino, M. Oren, F. Fiori, G. Gargari, P. Riso, C. Ciafardini, F. Mascaretti, M. Parpinel, A. Airoldi, M. Vangeli, P. Leone, P. Cantù, P. Lagiou, C. Del Bo', M. Vecchi, P. Carnevali, B. Oreggia, S. Guglielmetti, R. Bonzi, G. Bonato, M. Ferraroni, C. La Vecchia, R. Penagini, M. Mutignani, M. Rossi
Blood Bacterial DNA Load and Profiling Differ in Colorectal Cancer Patients Compared to Tumor-Free Controls
2021 M. Mutignani, R. Penagini, G. Gargari, S. Guglielmetti, M. Cintolo, A. Airoldi, P. Leone, P. Carnevali, C. Ciafardini, G. Petrocelli, F. Mascaretti, B. Oreggia, L. Dioscoridi, F. Cavalcoli, M. Primignani, F. Pugliese, P. Bertuccio, P. Soru, C. Magistro, G. Ferrari, M.C. Speciani, G. Bonato, M. Bini, P. Cantù, F. Caprioli, M. Vangeli, E. Forti, S. Mazza, G. Tosetti, R. Bonzi, M. Vecchi, C. La Vecchia, M. Rossi
Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy
2021 R. Berte', S. Mazza, M.R. Stefanucci, D. Noviello, S. Costa, C. Ciafardini, E. Mileti, M. Mapelli, S. Pasqualato, S. Pinto, A. Favale, M. Vecchi, M.F. Neurath, R. Atreya, M.C. Fantini, F. Facciotti, F. Caprioli
A wait-and-watch approach to small pancreatic neuroendocrine tumors : Prognosis and survival
2016 S. Massironi, R.E. Rossi, A. Zilli, G. Casazza, C. Ciafardini, D. Conte
Gastric neuroendocrine neoplasms and proton pump inhibitors : fact or coincidence?
2015 F. Cavalcoli, A. Zilli, D. Conte, C. Ciafardini, S. Massironi
Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis
2015 S. Massironi, A. Zilli, I. Fanetti, C. Ciafardini, D. Conte, M. Peracchi
Chromogranin A in diagnosing and monitoring patients with gastro-entero-pancreatic neuroendocrine neoplasms : a large series from a single institution
2014 S. Massironi, R.E. Rossi, G. Casazza, D. Conte, C. Ciafardini, M. Galeazzi, M. Peracchi
LA RIDUZIONE DEI MACROFAGI CD68+ TISSUTALI E LA DIMINUZIONE NELL'ESPRESSIONE MUCOSALE DI INTERLEUCHINA 17 SONO STRETTAMENTE CORRELATI CON LA RISPOSTA ENDOSCOPICA E CON LA GUARIGIONE DELLA MUCOSA A SEGUITO DI TERAPIA CON INFLIXIMAB IN PAZIENTI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI
2014 C. Ciafardini
Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: A transversal prospective study
2013 S. Massironi, F. Cavalcoli, R.E. Rossi, D. Conte, M.P. Spampatti, C. Ciafardini, U. Verga, P. Beck-Peccoz, M. Peracchi
Reduction of CD68(+) macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy
2013 F. Caprioli, F. Bose, R. L. Rossi, L. Petti, C. Vigano, C. Ciafardini, L. Raeli, G. Basilisco, S. Ferrero, M. Pagani, D. Conte, G. Altomare, G. Monteleone, S. Abrignani, E. Reali
Treatment of liver metastases in patients with digestive neuroendocrine tumors
2012 R.E. Rossi, S. Massironi, M.P. Spampatti, D. Conte, C. Ciafardini, F. Cavalcoli, M. Peracchi
Unusually aggressive type 1 gastric carcinoid : a case report with a review of the literature
2012 M.P. Spampatti, S. Massironi, R.E. Rossi, D. Conte, V. Sciola, C. Ciafardini, S. Ferrero, L. Lodi, M. Peracchi
Chronic atrophic gastritis associated with hyperparathyroidism : a prospective study
2011 S. Massironi, R. Rossi, M. Spampatti, D. Conte, C. Ciafardini, U. Verga, S. Corbetta, M. Peracchi
Contrast-enhanced ultrasonography in evaluating hepatic metastases from neuroendocrine tumours
2010 S. Massironi, D. Conte, V. Sciola, L. Pirola, S. Paggi, M. Fraquelli, C. Ciafardini, M.P. Spampatti, M. Peracchi.
Plasma chromogranin a response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors
2010 S. Massironi, D. Conte, D. Sciola, M. Spampatti, C. Ciafardini, L.V. Valenti, R. Rossi, M. Peracchi
Chromogranin A levels in chronic liver disease and hepatocellular carcinoma
2009 S. Massironi, M. Fraquelli, S. Paggi, A. Sangiovanni, D. Conte, V. Sciola, C. Ciafardini, M. Colombo, M. Peracchi
Plasma chromogranin A in patients with inflammatory bowel disease
2009 V. Sciola, S. Massironi, D. Conte, F. Caprioli, S. Ferrero, C. Ciafardini, M. Peracchi, M.T. Bardella, L. Piodi